These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Effect of a killer toxin of Pichia anomala to Pneumocystis. Perspectives in the control of pneumocystosis. Séguy N; Polonelli L; Dei-Cas E; Cailliez JC FEMS Immunol Med Microbiol; 1998 Sep; 22(1-2):145-9. PubMed ID: 9792073 [TBL] [Abstract][Full Text] [Related]
9. [Medical importance of yeast killer toxin]. Cerikcioğlu N Mikrobiyol Bul; 2003; 37(2-3):215-21. PubMed ID: 14593905 [TBL] [Abstract][Full Text] [Related]
10. From yeast killer toxins to antibiobodies and beyond. Magliani W; Conti S; Travassos LR; Polonelli L FEMS Microbiol Lett; 2008 Nov; 288(1):1-8. PubMed ID: 18785931 [TBL] [Abstract][Full Text] [Related]
11. Human natural yeast killer toxin-like candidacidal antibodies. Polonelli L; De Bernadis F; Conti S; Boccanera M; Magliani W; Gerloni M; Cantelli C; Cassone A J Immunol; 1996 Mar; 156(5):1880-5. PubMed ID: 8596040 [TBL] [Abstract][Full Text] [Related]
12. In vitro activity of a monoclonal killer anti-idiotypic antibody and a synthetic killer peptide against oral isolates of Candida spp. differently susceptible to conventional antifungals. Manfredi M; McCullough MJ; Conti S; Polonelli L; Vescovi P; Al-Karaawi ZM; Porter SR Oral Microbiol Immunol; 2005 Aug; 20(4):226-32. PubMed ID: 15943767 [TBL] [Abstract][Full Text] [Related]
13. A transphyletic anti-infectious control strategy based on the killer phenomenon. Conti S; Magliani W; Gerloni M; Salati A; Dieci E; Arseni S; Fisicaro P; Polonelli L FEMS Immunol Med Microbiol; 1998 Sep; 22(1-2):151-61. PubMed ID: 9792074 [TBL] [Abstract][Full Text] [Related]